Find Academic Supervisors

Deborah WaberView profile

Professor

• Neuropsychology
• Learning Disabilities
• Child Development
• +7 more

Deborah Waber, PhD is Professor of Psychiatry at Harvard Medical School and serves as Director of the Learning Disabilities Program in the Department of Neurology and Director of the Behavioral Science Core at the Translational Neuroscience Center at Boston Children's Hospital. Her work spans clinical practice, research, and academic leadership in pediatric neuropsychology and developmental disorders. Dr. Waber received her undergraduate degree in Psychology from the University of Pennsylvania in 1970, followed by a PhD in Developmental Psychology from Yale University in 1974. She completed her post-doctoral training at Boston Children's Hospital in 1974, where she subsequently joined the staff. Dr. Waber's research investigates the influence of endogenous and exogenous factors on children's cognitive and behavioral functioning within a developmental context. Her primary research interests include normative brain and behavioral development, developmentally based disabilities (particularly learning disabilities), and pediatric conditions that affect brain development. She approaches learning disabilities through a 'whole child' perspective, viewing them as variants of normal development where problems arise when community and school expectations don't align with a child's profile of strengths and weaknesses. Analysis of Dr. Waber's recent publications reveals a consistent focus on neurobehavioral aspects of learning disabilities, the impact of childhood cancer and other medical conditions on neurodevelopment, and the long-term and intergenerational effects of infant malnutrition. Her work frequently employs longitudinal designs and integrates multiple methodologies including neuropsychological assessment, neuroimaging, and behavioral observation. A significant portion of her research examines executive function, visual processing in learning disorders, and quality of life outcomes for children with learning disabilities. Dr. Waber has directed the Learning Disabilities Program at Boston Children's Hospital since 2011 and was promoted to Professor at Harvard Medical School in 2013. She has received grant support from major federal agencies including NIMH, NINDS, and NICHD throughout her career. Her clinical work focuses on improving the fit between children's cognitive profiles and educational environments. Dr. Waber leads the Behavioral Science Core in the Clinical Research Center and co-directs the Neurobehavior Core in the Translational Neuroscience Center. Her team conducts research on various aspects of pediatric neuropsychology, including the effects of medical treatments on cognitive development, assessment methodologies for learning disorders, and interventions to improve educational outcomes for children with learning disabilities.

Jamie O. LoView profile

Associate Professor

• Reproductive health
• Maternal substance use
• Paternal substance use
• +6 more

Jamie O. Lo, M.D., M.C.R. is an Associate Professor in the Department of Obstetrics and Gynecology and Department of Urology at Oregon Health & Science University (OHSU), a Core Scientist at the Oregon National Primate Research Center (ONPRC), and adjunct faculty in the College of Public Health at the University of Georgia. Her work integrates clinical obstetrics, reproductive research, and translational toxicology. Her educational background includes: B.A. in Molecular Cell Biology from University of California, Berkeley (2004) M.D. from Oregon Health & Science University (2008) M.C.R. from Oregon Health & Science University (2015) Residency in Obstetrics and Gynecology at University of Utah (2012) Fellowship in Maternal-Fetal Medicine at OHSU (2015) Dr. Lo's research centers on environmental impacts—particularly substance use including cannabis, alcohol, and methamphetamine—on reproductive health and fetal development. She investigates placental function, amniotic fluid dynamics, iron deficiency in pregnancy, and transgenerational effects of paternal substance exposure using clinical cohorts and nonhuman primate models. Her work bridges reproductive toxicology, obstetrics, and developmental biology to understand mechanisms of exposure-related complications. Analysis of her 15 most recent publications reveals dominant themes in prenatal cannabinoid exposure (THC/methamphetamine), placental health, and iron metabolism. Her research consistently employs rhesus macaque models to isolate biological mechanisms, with strong emphasis on translational applications for neonatal outcomes. Key trends include dose-response relationships in substance exposure, sex-specific developmental effects, and multi-organ impacts on pulmonary, cardiac, and neurological systems. Dr. Lo's research is funded by the National Institutes of Health (NIH), March of Dimes, and Silver Family Foundation. She serves as Co-Director of PMedIC (Pacific Northwest Biomedical Innovation Co-Laboratory), a collaboration between OHSU and Pacific Northwest National Laboratory, and as Recruitment Director for OHSU's NIH/NICHD Women's Reproductive Health Research K12 Program. She mentors residents through her role as Assistant OB/Gyn Residency Program Director for Research and Scholarship. As a Core Scientist at ONPRC, she leads a multidisciplinary team studying reproductive toxicology with advanced primate models. Her leadership extends to the Society for Reproductive Investigation (Grants Committee Chair) and Society for Maternal-Fetal Medicine (Publications Committee), where she shapes national clinical guidelines and research priorities.

• Cardiology
• Nephrology
• Hypertension
• +3 more

Jan Roland Petersen serves as a Clinical Associate Professor within the Department of Clinical Medicine at the University of Copenhagen, Denmark, specializing in Cardiology under Internal Medicine. His clinical and research activities are centered at Blegdamsvej 3, 2200 København N, with professional correspondence handled through regionsjaelland.dk institutional channels. His primary research domains include Cardiology, Nephrology, Hypertension, Thrombosis, Pulmonary Embolism, and Renal Medicine. Key contributions involve advanced cardiac imaging for pulmonary embolism assessment, novel anticoagulation strategies for thrombotic disorders like HIT, and CT-guided protocols for acute chest pain management. Earlier foundational work examined renal hemodynamics in chronic kidney disease and pharmacological impacts of ACE inhibitors on cardiac diastolic function. Publication analysis reveals a chronological shift from nephrology-focused hypertension research (1996-2001) toward acute cardiovascular interventions (2016-2018). Recent work emphasizes translational cardiology through randomized trials like CATCH-2, while historical studies established critical relationships between renal arterial indices and chronic kidney disease progression. Methodologically, his work spans clinical trials, imaging modalities, and hemodynamic assessments. No scientific awards or major honors are documented in available sources. Student mentorship, grant funding, and laboratory affiliations are not referenced in the provided materials, indicating these aspects either fall outside his current responsibilities or lack public documentation.

Bruno ChinkoView profile

Senior Lecturer

• Human Physiology
• Pharmacology
• Cardiovascular Research
• +4 more

Bruno Chinko is a Senior Lecturer and Researcher in the Human Physiology department at the University of Port Harcourt, Nigeria. His academic profile demonstrates consistent research productivity with publications spanning over a decade from 2011 to 2025. He has established himself as a significant contributor to medical research in Nigeria, with his work ranking in the top 4% on Academia.edu platform. Dr. Chinko's research interests focus on the intersection of natural products and human physiology, with particular emphasis on cardiovascular health, metabolic disorders, and immunological responses. His work frequently employs animal models, especially Wistar rats, to investigate the physiological effects of various substances and conditions. Key research themes include phytochemical analysis of medicinal plants, effects of intermittent fasting on cardiac biomarkers, hypertension and diabetes comorbidities, and maternal immunological adaptations during pregnancy. Analysis of his recent publications reveals a strong trend toward investigating the pharmacological properties of Nigerian medicinal plants and their potential applications in managing chronic diseases. His work increasingly addresses public health concerns relevant to the Niger Delta region, including environmental health impacts and metabolic disorders in local populations. The research demonstrates methodological consistency using standard laboratory protocols and statistical analyses. Top 4% ranking on Academia.edu platform Dr. Chinko's work demonstrates significant collaborative efforts across Nigerian institutions, with co-authorship on numerous studies involving researchers from various medical and research facilities. His research program appears well-integrated with local health challenges, particularly those affecting the Niger Delta region, with studies examining environmental exposures like gas flaring and their health impacts. The volume and consistency of his publications suggest an active research laboratory with multiple ongoing projects. His research on maternal health, including CD4/CD8 parameters in pregnancy and birth preparedness, indicates involvement in clinical research that directly impacts healthcare practices in Nigeria. The breadth of his work, spanning from basic pharmacological investigations to epidemiological studies, demonstrates a comprehensive approach to addressing health challenges in his community.

Christina SpenglerView profile

Adjunct Professor

• Exercise Physiology
• Respiratory Physiology
• Cardiovascular Physiology
• +4 more

Prof. Christina Spengler is an Adjunct Professor and Deputy Head of the Institute of Human Movement Sciences and Sport at ETH Zürich. Her research focuses on mechanisms governing respiratory, cardiovascular, neuromuscular, and metabolic systems during exercise and rest, aiming to develop training strategies for athletic performance and clinical rehabilitation. She leads the Exercise Physiology Lab, established in 2013, using advanced technologies to assess respiratory mechanics, cardiovascular function, and muscle performance. Her work targets patients with cardiorespiratory, neuromuscular, and metabolic disorders. Education: MSc in Biochemistry (ETH Zurich), PhD in Physiology (ETH Zurich), medical degree (University of Zurich). Postdoctoral research at Harvard T.H. Chan School of Public Health investigated respiratory control and circadian rhythms. Awards include the 2001 Scientific Award of the Swiss Society of Sports Medicine. Research interests span exercise-induced physiological adaptations, respiratory muscle training, and wearable sensor technologies for health monitoring. She teaches courses in Exercise Physiology and supervises advanced research projects. Key contributions include studies on footwear biomechanics, arrhythmia management in athletes, and sleep-cardiac interactions. Her lab develops innovative training regimens and technologies, such as magnetic phrenic nerve stimulation protocols and accelerometer-integrated devices for activity tracking. Ongoing projects explore exercise impacts on chronic diseases and the reliability of physiological testing methods.

• Grief Studies
• Psychological Health
• Emergency Care
• +3 more

Nina Carlsson is a registered nurse and PhD holder in nursing science from Linnaeus University (2022), specializing in grief reactions among family members affected by sudden cardiac arrest. She is affiliated with the Faculty of Health and Life Sciences and the Department of Health and Caring Sciences. Her research focuses on psychological distress, prolonged grief, and support interventions for bereaved families. She co-leads the innovative Cardiac Arrest REsearch (iCARE) group and participates in the CESAR research network. Key contributions include studies on cognitive function in cardiac arrest survivors and validation of quality-of-life measurement tools. Her work addresses gaps in understanding grief dynamics following sudden death and aims to inform clinical support strategies. Education: B.A. in Nursing (2003) PhD in Nursing Science, Linnaeus University (2022) Research Projects: Grief and Health: Examines grief’s impact on mental and physical health iCARE Group: Studies sudden cardiac arrest outcomes and bereavement support Publications (Selected): 2025: Cardiac arrest survivors’ cognitive function analysis (Resuscitation) 2023: Factors in prolonged grief among bereaved families (Journal of Cardiovascular Nursing) 2022: Qualitative study on lived experiences of sudden cardiac arrest loss (Death Studies) Labs/Teams: iCARE Group, CESAR Network.

Gerardo TurcattiView profile

Adjunct Professor

• Drug Screening
• Chemical Biology
• Bio-analytical Chemistry
• +5 more

Gerardo Turcatti is an Adjunct Professor at the School of Life Sciences (EPFL), leading the Biomolecular Screening Facility (BSF) and the Biomolecular Screening Core Facility. He holds roles in SSV-Teaching and directs the ACCESS program under the NCCR-Chemical Biology initiative. With a Master's in Chemical Engineering (University of Geneva) and a PhD in Chemistry and Biochemistry (EPFL, where he won the best doctoral thesis award), his expertise spans multidisciplinary R&D in drug screening, chemical biology, and bio-analytical chemistry. His research focuses on high-throughput screening technologies, including holographic imaging for cardiomyocyte dynamics and red blood cell storage studies. He has pioneered platforms for malaria drug discovery and cancer therapeutics, leveraging 3D tumoroid models and combinatorial chemistry. His work extends to antiviral research, including SARS-CoV-2 inhibitors and canine distemper virus studies, and includes innovations in nucleic acid sequencing technologies through his former role as CTO of Manteia S.A. Key Projects: ACCESS platform, BSF facility, Next-Gen sequencing tech development Teaching: Leads the 'Methods: from disease models to therapy' course, integrating hands-on platform rotations in life sciences Labs/Teams: Directs EPFL's Biomolecular Screening Facility and collaborates with industry and academic partners Publications emphasize translational applications, including drug repurposing, cardiovascular toxicity screening, and red blood cell storage optimization. His contributions bridge academic research and industrial innovation, with over 100 peer-reviewed articles and patents in chemical biology and drug discovery.

Müller ChristophView profile

Research Professor

• Protein crystallography
• RNA polymerase transcription
• Integrated structural biology
• +4 more

Christoph Müller is a Research Professor leading the Structural and Computational Biology Unit at EMBL Heidelberg since 2007. He previously served as Deputy Head at EMBL Grenoble (2000-2007) and has been a Senior Scientist at EMBL since 2000. His research focuses on protein crystallography, RNA polymerase mechanisms, and integrated structural biology. Key contributions include studies on RNA polymerases I/III transcription, chromatin modifying complexes, and transcription factor interactions. Education: PhD in X-ray Crystallography & Biochemistry (1991), University of Freiburg MSc in Chemistry & Biochemistry (1986), University of Freiburg Postdoctoral training at Harvard University (1992-1995) and University of Freiburg (1991) His work bridges structural biology with functional mechanisms, employing cutting-edge techniques like cryo-EM and X-ray crystallography. Major achievements include solving the structure of the 14-subunit RNA polymerase I and elucidating promoter-opening mechanisms in RNA polymerase III. Awards: ERC Advanced Investigator Grant (2013) EMBO Membership (2005) Steinhofer Award (2003) His research group investigates transcriptional regulation at molecular and structural levels, with recent work exploring BET protein interactions and tRNA modification pathways. Collaborations span structural biology, epigenetics, and developmental biology.

• Stem Cell Research
• Cardiac Biology
• Tissue Engineering
• +3 more

Prof. P.C.J.J. Passier holds dual positions as Full Professor in Applied Stem Cell Technologies and the TechMed Centre at the University of Twente. His research focuses on cardiac regeneration and disease modeling using pluripotent stem cells, with contributions to tissue engineering and in vitro toxicity assessment. Key collaborations span cardiovascular biology, biomedical engineering, and pharmacology. Research interests include cardiomyocyte differentiation, engineered heart tissues, and drug safety screening platforms. His work advances personalized medicine through cardiac tissue models and mechanistic insights into lineage commitment. Recent innovations include FORCETRACKER for contractile property analysis and micro-engineered heart tissues with enhanced functionality. He leads interdisciplinary teams in developing translational cardiac models, emphasizing clinical relevance and toxicology applications. Contributions include over 90 research outputs, with a focus on stem cell-derived cardiomyocytes and 3D bioprinting technologies.

Vivek PandyaView profile

Academic

• Ophthalmology
• Vitreoretinal Surgery
• Medical Retina
• +3 more

Dr Vivek Pandya is a Clinical Lecturer at the University of Sydney and holds academic appointments at the University of New South Wales. He is affiliated with the Central Clinical School and the Save Sight Institute within the Faculty of Medicine and Health. His clinical expertise focuses on vitreoretinal surgery, medical retina, and complex cataract surgery. Dr Pandya completed his medical training at the University of New South Wales and ophthalmology residency at Sydney Eye Hospital, followed by subspecialty fellowships in medical retina (Westmead Hospital) and vitreoretinal surgery (University of British Columbia, Vancouver, Canada). He has been recognized with prestigious awards, including the RANZCO Leadership Grant and Excellence in Teaching Award. Education: BSc(Med) from University of New South Wales MBBS(Hons) from University of New South Wales MMed (Ophthalmic Science) from University of Sydney Research Interests: Dr Pandya’s work spans clinical and surgical advancements in retinal diseases, including age-related macular degeneration, diabetic retinopathy, and surgical innovations in retinal detachment repair. He actively contributes to clinical trials for novel retinal therapies and emphasizes international eye care initiatives in Cambodia and Fiji. Publications: His 15 most recent articles (2008–2017) focus on retinal pathology, ocular infections, and surgical outcomes. Key themes include choroidal neovascularisation, fungal keratitis, and tattoo-associated uveitis, reflecting his clinical expertise in complex retinal and infectious cases. Awards: 2020 RANZCO Leadership Grant Excellence in Teaching Award (2018) RANZCO/Bayer Scholarship Advising & Grants: Dr Pandya trains retinal fellows, ophthalmology registrars, and medical students. He has developed a vitreoretinal surgery unit at Liverpool Hospital and participates in international development programs. Labs/Teams: Involved with the Save Sight Institute and Retina Associates, contributing to clinical research and surgical innovation.

Lars HarbaumView profile

Clinical Professor

• Pulmonary Medicine
• Internal Medicine
• Critical Care Medicine
• +3 more

Dr. Lars Harbaum is a Clinical Professor and senior physician specialized in Internal Medicine and Pneumology at the Faculty of Medicine, University of Hamburg. He is affiliated with the Center for Oncology and II. Medical Clinic and Polyclinic at the University Medical Center Hamburg-Eppendorf (UKE). His expertise focuses on pulmonary hypertension, right ventricular function, and translational research in cardiovascular medicine. Specializes in internistic intensive care medicine and pulmonary hypertension treatment Active in clinical and translational research involving proteomics, genetics, and omics approaches Conducts studies on biomarker discovery, risk stratification, and therapeutic targeting in pulmonary arterial hypertension (PAH) His research spans over 25 peer-reviewed articles since 2013, with recent work emphasizing plasma proteome analysis and genetic determinants of cardiovascular outcomes. He collaborates with international teams in Europe and North America on PAH subtyping and patient stratification.

Shuo ZhouView profile

Lecturer

• Interpretable Machine Learning
• Medical Image Analysis
• Statistical Learning Theory

Dr. Shuo Zhou is a Lecturer in Machine Learning at the University of Sheffield's School of Computer Science, holding dual roles as Deputy Head of AI Research Engineering. He specializes in interpretable machine learning for medical imaging and neuroimaging analysis, with contributions to open-source tools like PyKale. Education: MSc Advanced Computer Science (2017), University of Sheffield PhD in Machine Learning (2022), University of Sheffield Research Interests: Interpretable ML methods for clinical decision-making Medical image analysis (cardiac MRI, fMRI) Statistical learning theory with domain adaptation Grants & Leadership: Co-PI: EPSRC grant (£445k) for neuroimaging biomarkers in chronic pain (2023-2025) PI: Turing 2.0 project (£20k) for machine learning infrastructure (2022-2023) Labs & Teams: Core developer of PyKale open-source library Member of Machine Learning research group

Luc FlorackView profile

Professor

• Medical Imaging
• Differential Geometry
• MRI Techniques
• +5 more

Luc Florack is a Full Professor in the Applied Differential Geometry group at Eindhoven University of Technology (TU/e). His research focuses on multiscale and differential geometric representations of medical imaging data, particularly in MRI techniques like diffusion and tagging MRI. He applies these methods to connectomics and myocardial function analysis. He holds an MSc in theoretical physics and a PhD in medical image analysis from Utrecht University. He has authored nearly 200 peer-reviewed papers and served on editorial boards and conference committees. His work includes developing the Sheet Probability Index (SPI) for white matter analysis and stability metrics for optic radiation tractography. Affiliations: EAISI, EAISI Health, Center for Analysis, Scientific Computing & Appl., Applied Differential Geometry Research interests include differential geometry applications to image analysis, tensor calculus, and partial differential equations. His recent work emphasizes clinical workflow integration of mathematical techniques. He has contributed to international conferences and holds roles in Dutch academic organizations like 3TU.AMI and NWO's Mathematics Advisory Board. Publications span neuroimaging, cardiovascular MRI, and tractography validation. His methods address challenges in quantifying brain sheet structures and improving surgical prediction accuracy.

Kevin DammanView profile

Clinical Professor

• Heart Failure
• Cardiorenal Interaction
• Clinical Cardiology
• +3 more

Dr. Kevin Damman is a Clinical Professor and Cardiologist at the University Medical Center Groningen (UMCG), affiliated with the Faculty of Medical Sciences at the University of Groningen. He leads the heart transplant and left ventricular assist device program, focusing on advanced heart failure and cardiorenal interactions. His research emphasizes improving acute heart failure treatments, including SGLT2 inhibitors and diuretic therapy optimization. He holds editorial roles at the European Journal of Heart Failure and chairs the MCS Working Group of the Netherlands Society of Cardiology. Dr. Damman is a co-investigator in pivotal studies like EMPA-RESPONSE-AHF and ADVOR, exploring novel therapies in heart failure. His research spans acute heart failure pathophysiology, cardiorenal syndrome, and translational medicine through initiatives like the TransplantLines biobank. He contributes to clinical guidelines on diuretic titration and natriuresis monitoring. Dr. Damman actively participates in international working groups (ESC HFA) and registries (EUROMACS), shaping global standards in heart failure care. His work bridges clinical practice and research, aiming to enhance patient outcomes through innovative therapies and precision medicine approaches. Grants and studies include leadership roles in the PUSH-AHF and ADVOR trials, investigating decongestive therapies and acetazolamide respectively. He collaborates with multidisciplinary teams across Europe, emphasizing the integration of renal function assessment into heart failure management strategies. Dr. Damman’s contributions extend to public engagement through expert commentary on high-profile transplant cases and emerging treatments in cardiovascular medicine.

Mariappan MuthuchamyView profile

Professor

• Cardiac Muscle Physiology
• Lymphatic System Biology
• Mechanotransduction
• +4 more

Mariappan Muthuchamy is a Professor of Medical Physiology and Director of the Cardiovascular Research Institute at Texas A&M University. His research focuses on cardiac and lymphatic muscle contraction mechanisms, mechanotransduction signaling, and the interplay between mechanical forces and cellular functions. He holds the Lyndon Baines Johnson Research Award. Education: B.S. Chemistry, Madurai Kamaraj University, India (1980) M.S. Biochemistry, Madurai Kamaraj University, India (1983) Ph.D. Biochemistry/Molecular Biology, Madurai Kamaraj University, India (1991) Research Interests: Dr. Muthuchamy’s work explores molecular mechanisms underlying cardiac muscle dynamics in health and disease, including thin filament activation, crossbridge kinetics, and mechanotransduction. His lab employs molecular, cellular, and structural techniques to study myofilament regulation. He pioneered methods to exchange myofibrillar proteins via transgenic manipulation. Additionally, he investigates lymphatic muscle contraction, its role in fluid transport, and its unique smooth-striated hybrid contractile properties. Recent work includes studying lymphatic dysfunction in metabolic disorders and inflammatory conditions using advanced tools like Atomic Force Microscopy (AFM) and microphysiological systems (e.g., Lymphangion-Chip). Key Findings: Established AFM-fluorescence microscopy fusion for mechanotransduction studies. Discovered lymphatic muscle’s role in systemic fluid dynamics and disease pathogenesis (e.g., lymphedema, metabolic syndrome). Linked inflammatory mediators (e.g., IL-1β, TNF-α) to lymphatic pump impairment. Awards: Lyndon Baines Johnson Research Award (Lyndon Baines Johnson Foundation) Lab & Collaborations: His lab includes Research Assistant Akshaya Narayanan (akshaya.narayanan@tamu.edu). Collaborations focus on translational research in cardiovascular and lymphatic physiology, leveraging engineered tissues and animal models. Ongoing projects target lymphatic dysfunction in amyotrophic lateral sclerosis, Duchenne muscular dystrophy, and metabolic diseases. Labs/Teams: Cardiovascular Research Institute (CRI) at Texas A&M, with interdisciplinary teams studying mechanobiology, integrin signaling, and lymphatic-inflammatory interactions.